← Open Payments lookup

RACHEL SAVAGE: Open Payments

NPI 1588209779 · FORT WORTH, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,763 in 53 payments from 26 companies in 2025. Trend: 2023 $2,022 · 2024 $2,631 · 2025 $1,763

Food & beverage: $1,165Long term medical supply or device loan: $598
CompanyPaymentsAmount
Novartis Pharmaceuticals Corporation8$643
Celgene Corporation4$113
Incyte Corporation4$101
SOBI, INC3$85
Merck Sharp & Dohme LLC3$80
Janssen Biotech, Inc.3$76
Deciphera Pharmaceuticals Inc.2$61
Lilly USA, LLC2$60
AstraZeneca Pharmaceuticals LP2$55
ARRAY BIOPHARMA INC3$54

Products named: KISQALI, REBLOZYL, KEYTRUDA, Doptelet, VERZENIO, CALQUENCE, BRAFTOVI, JAKAFI.

Industry payments across TX — which companies pay providers there.